Validated Liquid Chromatography-Tandem Mass Spectroscopy Method for the Simultaneous Quantification of Four Antimycotic Agents in Human Serum

被引:22
作者
Chahbouni, Abdel [1 ]
Wilhelm, Abraham J. [1 ]
den Burger, Jeroen C. G. [1 ]
Sinjewel, Arno [1 ]
Vos, Rene M. [1 ]
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Clin Pharmacol & Pharm, NL-1081 HV Amsterdam, Netherlands
关键词
itraconazole; voriconazole; fluconazole; posaconazole; antimycotics; INVASIVE FUNGAL-INFECTIONS; HUMAN PLASMA; PRACTICE GUIDELINES; ADVERSE EVENTS; VORICONAZOLE; ITRACONAZOLE; POSACONAZOLE; ASPERGILLOSIS; SPECTROMETRY; SAFETY;
D O I
10.1097/FTD.0b013e3181e185fd
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A liquid chromatography-tandem mass spectrometry method was developed and validated for the simultaneous quantification of voriconazole, fluconazole, posaconazole, itraconazole, and hydroxyitraconazole in human serum. A simple protein precipitation was used as sample pretreatment with ketoconazole as the internal standard. Chromatographic separation was performed on a Waters Alliance 2795 liquid chromatography system using a XBridge RP18 column. The mass spectrometer from Micromass was equipped with an electrospray ionization probe operating in the positive mode using multiple reaction monitoring. The method was linear over the range of 0.01 to 5.00 mg/L for itraconazole, 0.01 to 5.00 mg/L for OH-itraconazole, 0.02 to 10.00 mg/L for voriconazole, 0.06 to 30.00 mg/L for fluconazol, and 0.02 to 10.00 mg/L for posaconazole. The between-and within-run accuracy ranged from 92% to 110%. The between-and within-run imprecision of the method was less than 11%. The reported method provided the necessary linearity, precision, and accuracy to allow the determination of four antimycotic agents for therapeutic drug monitoring and pharmacokinetic-pharmacodynamic studies.
引用
收藏
页码:453 / 457
页数:5
相关论文
共 29 条
[1]   High voriconazole trough levels in relation to hepatic function: how to adjust the dosage? [J].
Alffenaar, Jan-Willem C. ;
de Vos, Tessa ;
Uges, Donald R. A. ;
Daenen, Simon M. G. J. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (02) :262-263
[2]   Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications [J].
Andes, David ;
Pascual, Andres ;
Marchetti, Oscar .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :24-34
[3]  
[Anonymous], 2001, FED REGISTER, V66, P28526
[4]  
Brüggemann RJM, 2008, THER DRUG MONIT, V30, P403, DOI 10.1097/FTD.0b013e31817b1a95
[5]   Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses [J].
Chambers, Erin ;
Wagrowski-Diehl, Diane M. ;
Lu, Ziling ;
Mazzeo, Jeffrey R. .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2) :22-34
[6]   Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection [J].
Chhun, Stephanie ;
Rey, Elisabeth ;
Tran, Agnes ;
Lortholary, Olivier ;
Pons, Gerard ;
Jullien, Vincent .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 852 (1-2) :223-228
[7]   APPLICATION ISSUES IN BIOANALYTICAL METHOD VALIDATION, SAMPLE ANALYSIS AND DATA REPORTING [J].
DADGAR, D ;
BURNETT, PE ;
CHOC, MG ;
GALLICANO, K ;
HOOPER, JW .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1995, 13 (02) :89-97
[8]   Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies:: Evidence from a meta-analysis of 3,597 patients [J].
Glasmacher, A ;
Prentice, A ;
Gorschlüter, M ;
Engelhart, S ;
Hahn, C ;
Djulbegovic, B ;
Schmidt-Wolf, IGH .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4615-4626
[9]   Therapeutic drug monitoring for triazoles [J].
Hope, William W. ;
Billaud, Eliane M. ;
Lestner, Jodie ;
Denning, David W. .
CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) :580-586
[10]  
Imhof A, 2006, SWISS MED WKLY, V136, P739